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Induction of calbindin D-28K in Madin-Darby bovine kidney
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Induction of calbindin D-28K in Madm-Darby bovine kidney cells by
1,25(OH)2D3. Renal calbindin D-28K is a calcium binding protein,
localized to the distal nephron, whose expression is reduced in vitamin
D deficiency and increased upon administration of I ,25(OH)2D3, the
active form of vitamin D. Investigation into the molecular regulation of
renal calbindin D-28K expression has been limited by the lack of an
established cell line which expresses calbindin D-28K in a vitamin D
responsive manner. In the studies described here, we compared the
expression of calbindin D-28K and the vitamin D receptor (VDR) in
four renal cell lines: Madin-Darby bovine kidney (MDBK) cells, Madin-
Darby canine kidney (MDCK) cells, LLC-PK1 pig kidney cells and
opossum kidney (OK) cells. We report that MDBK cells express the
highest relative levels of calbindin D-28K and the VDR, and that
I ,25(OH)2D3 increases calbindin D-28K expression in these cells. No
expression of calbindin D-28K was detected in MDCK, LLC-PK1 or
OK cells. Kinetic studies indicated that calbindin D-28K protein
increased with time for up to 24 hours after a single dose of 1 ,25(OH)2D3
(lO— as) in MDBK cells. Immunofluorescence studies indicated that in
control MDBK cells, the majority of calbindin D-28K was localized in
cytosol, with a definite concentration in the pen-nuclear region. In
1 ,25(OH)2D3 treated cells, calbindin D-28K was enhanced in cytosol
and was detected within the nucleus. In contrast to heterogeneous
primary culture systems, in which a minority of cells express calbindin
D-28K, virtually all MDBK cells expressed calbindin D-28K, even in
the absence of l,25(OH)2D3. In summary, MDBK cells represent the
first established renal cell line identified which expresses calbindin
D-28K in a vitamin D responsive manner, providing a model in which to
examine the molecular regulation of calbindin D-28K by 1,25(OH)2D3.
Renal calbindin D-28K is a vitamin D dependent calcium
binding protein localized exclusively to distal tubules and
collecting ducts [1, 2]. In vivo, renal caibindin D-28K expres-
sion is reduced in vitamin D deficiency, and increases upon
administration of 1 ,25(OH)2D3, the active form of vitamin D [3,
4]. Although no function has yet been definitively assigned to
calbindin D-28K, several roles have been suggested, including
calcium transport (2) and enzyme activation [5, 6]. Investiga-
tions into the function and regulation of renal calbindin D-28K
expression have been limited by the lack of an established cell
line which expresses calbindin D-28K in a vitamin D responsive
manner. To date, the only successful in vitro models exhibiting
I ,25(OH)2D3 dependent expression of renal calbindin D-28K
are primary culture systems [2, 7, 8]. Besides the experimental
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difilculties in working with primary culture, these systems are
heterogeneous, and the epithelial cells display both distal and
proximal tubular characteristics. In avian primary cultures, for
example, only S to 10% of cells express calbindin D-28K [7]. We
have reported that Madin-Darby bovine kidney (MDBK) cells
(an established bovine renal epithelial cell line) express the
vitamin D receptor (VDR) and calbindin D-28K [9, 10]. In the
studies described here, we compared the expression of the
VDR and calbindin D-28K in MDBK cells with three additional
renal cell lines, LLC-PK1 (pig kidney) cells, OK (opposum
kidney) cells and Madin-Darby canine kidney (MDCK) cells to
determine which, if any, of these cell lines might provide a
suitable in vitro model which mimics calbindin D-28K expres-
sion in vivo. We first compared the expression of the VDR and
calbindin D-28K in these cell lines and report the highest
relative levels of the two proteins in MDBK cells. No caibindin
D-28K was detected in LLC-PK1, OK or MDCK cells. Further,
we demonstrate that 1 ,25(OH)2D3 enhances the expression of
caibindin D-28K in MDBK cells, offering the first report of an
established renal cell line which expresses calbindin D-28K in a
vitamin D responsive manner.
Methods
Cell culture
Stock cultures of Madin-Darby bovine kidney (MDBK),
Madin-Darby canine kidney (MDCK) cells and LLC-PK1 cells
were obtained from ATCC (Rockville, Maryland, USA) and
maintained in Dulbecco's modified Eagle's medium (Gibco
BRL, Burlington, Ontario, Canada) supplemented with 10%
newborn calf serum (Gibco BRL). Cells were plated at a density
of 1.5 x iO cells/mi in 60 mm dishes and grown to confluence.
OK (opossum kidney) cells were obtained from ATCC, grown
in RPMI 1640 medium (Gibco BRL) supplemented with 10%
fetal calf serum (Woodlyn Laboratories, Guelph, Ontario, Can-
ada), plated at a density of i0 cells/mi and allowed to reach
confluence. Cell proliferation was assessed as 3H-thymidine
incorporation into DNA as described [9].
In some experiments, confluent cells were changed to serum-
free DMEM for 24 hours prior to processing or treatment with
1 ,25(OH)2D3 (Biomol Research Laboratories, Plymouth Meet-
ing, Pennsylvania, USA) or vehicle (absolute ethanol) for up to
24 hours. The effect of cycloheximide on calbindin D-28K
expression was studied by exposure of serum free MDBK cells
to 2 M cycloheximide for one hour, followed by treatment with
1 ,25(OH)2D3 or ethanol for 24 hours.
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Cells were harvested by scraping, washed with ice-cold PBS
and lysed by vortexing for two minutes with hypotonic buffer (1
mM NaHCO3, 5 mri MgC12, 5 mM dithiothreitol, 100 M
phenylmethyl sulfonyl fluoride and 20 g/ml leupeptin, pH 7.5).
Ice-cold Tns-EGTA buffer was added to the cell lysate to give
a final concentration of 50 m Tns-Base and 500 ItM EGTA. A
post-nuclear fraction was prepared by centrifugation of total
cell homogenates at 500 g for five minutes at 4°C. The post-
nuclear fraction was centrifuged further at 100,000 g for one
hour at 4°C to prepare a cytosolic fraction which was used for
calbindin D-28K analysis. Whoie bovine kidney, obtained from
slaughterhouse and kept frozen at —20°C, was homogenized in
hypotonic buffer for preparation of cytosolic fractions as de-
scribed above. Protein concentration was determined by the
method of Bradford [11].
Immunoblotting
Proteins from cytosolic extracts or total homogenates of
MDBK, MDCK, LLC-PK1, OK cells or bovine kidney were
separated on 15% SDS-poiyacrylamide gels and electrophoret-
ically transferred to nitrocellulose. The effectiveness of the
transfer was monitored by reversibly staining the nitrocellulose
with 0.2% Ponceau S in 3% trichioroacetic acid. Non-specific
binding sites were saturated by incubation of nitrocellulose with
0.5% skim milk in PBS (Gibco BRL) for two hours. The
membranes were then washed in PBS containing 0.1% Tween
20 and incubated for two hours at 37°C with a mouse monoclo-
nat anti-calbindin D-28K (Sigma Immunochemicals, St. Louis,
Missouri, USA) diluted 1:200. This antibody, directed against
chick intestinal calbindin D-28K, does not recognize the closely
related calcium binding protein calretinin [12]. Following wash-
ing, filters were incubated for one hour at room temperature
with biotinylated donkey anti-mouse IgG (1:1,000), washed,
and incubated for 20 minutes at room temperature with strepta-
vidin peroxidase (Jackson Immunoresearch Laboratories, West
Grove, Pennsylvania, USA). In some experiments, parallel
samples were immunoblotted with polyclonal rabbit anti-rat
renal calbindin D-28K antiserum diluted 1:200 (provided by S.
Christakos, University of Medicine and Dentistry of New
Jersey) followed by biotinylated goat anti-rabbit IgG (1:2,000).
In all experiments, the peroxidase product was detected with
4-chloro-1-naphthol (625 pg/m1 in PBS with 20% methanol and
0.12% H202). Nonspecific binding, assessed in the absence of
primary antibodies, was negligible.
Immunofluorescence
MDBK, MDCK, LLC-PK1 or OK cells were plated on glass
coverslips in 35 mm dishes at a density of 4 x l0 cells/mi and
incubated in the appropriate growth medium for 36 hours. In
some experiments, cells were changed to serum-free medium 24
hours prior to treatment with 1,25(OH)2D3 or ethanol. Cells
were washed with ice-cold PBS and fixed in ethanol for 20
minutes at —20°C. Cells were then washed again and non-
specific binding sites were blocked overnight at 4°C in 0.5%
skim milk, 0.2% sodium azide in PBS. Cells were washed again
and incubated at room temperature with monoclonal anti-cal-
bindin D-28K (1:10) or with a distal tubule marker monoclonal
antibody (MAB 474, Chemicon International, Temecula, Cali-
fornia, USA) for one hour. Following washing, cells were
incubated for one hour at room temperature with a FITC-
conjugated donkey anti-mouse IgG (for anti-calbindin D-28K)
or FITC-conjugated goat anti-rabbit IgG (for MAB 474), diluted
1:50 (Jackson Immunoresearch Laboratories). Cells were
washed, mounted on slides and photographed using a Zeiss
microscope equipped with epi-fluorescence. Nonspecific bind-
ing, assessed in sections incubated in the absence of primary
antibody, was negligible for both antibodies.
ELISA for calbindin D-28K
Calbindin D-28K was quantitated by ELISA techniques
based on the method of Miller and Norman [13]. Standard rat
recombinant calbindin D-28K (SWANT, Bellizona, Switzer-
land) and cytosolic fractions derived from MDBK cells were
incubated overnight with monoclonal anti-calbindin D-28K (1:
80,000) in wells coated with 10 ng calbindin D-28K. Wells were
washed and incubated with an alkaline phosphatase donkey
anti-mouse IgG antibody (1:10,000). Mter washing, p-nitrophe-
nyl phosphate in diethanolamine buffer (1 mg/ml) was added.
Reactions were terminated after 30 minutes with 1 N NaOH and
absorbance at 405 nm was determined using a Bio-Tek mi-
croplate reader. Calbindin D-28K in the samples was calculated
from a standard curve obtained by plotting absorbance against
the log of calbindin D-28K; absorbance increased linearly up to
200 ng calbindin D-28K.
VDR analysis
VDR numbers were assayed by 3H-l,25(OH)2D3 binding as
described in Simboli-Campbell et al [9]. Cells were homoge-
nized in high salt buffer (10 mrs Tris-HC1, 1 mts EDTA, 5 mM
dithiothreitol, 10 mri molybdate, 0.02% soybean trypsin inhib-
itor, 300 mM KCI, pH 7.6) and centrifuged (105,000 g, 1 hr) to
yield a nuclear extract. Extracts (1.0 mg protein/mi) were
incubated with 0.5 nM [3H]-1 ,25(OH)2D3 (Amersham, Oakville,
Ontario, Canada) overnight at 4°C. Bound and free hormones
were separated by addition of dextran-coated charcoal, incuba-
tion for 15 minutes and centrifugation at 3500 g for 15 minutes.
Bound [3H]- 1 ,25(OH)2D3 in the supernatants was counted in a
Beckman liquid scintillation counter. Data for specific binding
of 3H- 1 ,25(OH)2D were generated by subtraction of nonspe-
cific binding, assessed in parallel tubes incubated with 200-fold
excess of unlabeled I ,25(OH)2D3, from total 3H- 1 ,25(OH)2D3
binding.
Statistical analysis
Data are expressed as mean standard error. Statistical
analysis was evaluated using Student's i-test or ANOVA, as
appropriate. Differences between means were considered sta-
tistically significant if a P value less that 0.05 was obtained.
Materials
All chemicals were obtained from Sigma Chemicals Corp.,
St. Louis, Missouri, USA unless otherwise stated.
Results
Expression of calbindin D-28K, VDR and distal tubule
marker
Calbindin D-28K expression was assessed in the four renal
cell lines by immunoblotting. Cytosolic proteins from each of
the cell lines were separated on 15% SDS-polyacrylamide gels
Fig. 1. Expression of immmunoreactive calbindin D-28K in MDBK,
MDCK, LLC-PK1 and OK cells. Cells were grown in serum containing
media as described in the Methods and were harvested by scraping.
Bovine kidney was obtained from slaughterhouse. Cytosolic proteins
(50 jig) were separated on 15% SDS PAGE, transferred to nitrocellulose
and blotted as described with either anti-chick intestinal calbindin
D-28K monoclonal antibody (A) or anti-rat renal calbindin D-28K
polyclonal antibody (B). In each panel, samples were derived from
bovine kidney (lane I), MDBK cells (lane 2), MDCK cells (lane 3),
LLC-PK1 cells (lane 4) and OK cells (lane 5).
and, visualized after immunoreaction with a monoclonal anti-
body directed against chick intestinal calbindin D-28K. In
extracts from MDBK cells and bovine kidney, a single immu-
noreactive protein at approximately 28 kDa is detected by this
antibody (Fig. 1A, lanes 1 and 2). The electrophoretic mobility
of this protein is identical to that of pure recombinant rat
calbindin D-28K (not shown). Calbindin D-28K is not detect-
able in immunoblots of MDCK, LLC-PK or OK cell extracts
(Fig. 1, lanes 3 to 5). As shown in Figure 1B, similar results are
obtained when parallel samples were immunoblotted with poly-
clonal rabbit anti-rat renal calbindin D-28K antiserum. Al-
though Celio et al [12] have reported that the monoclonal
antibody directed against intestinal calbindin D-28K does not
cross react with the closely related 27 kDa calcium binding
protein, cairetinin, we tested the possibility that the anti-
calbindin D-28K antibody might be recognizing calretinin in
these cells by immunoblotting MDBK cell extracts with anti-
calretinin polyclonal antibody (SWANT, Bellizona, Switzer-
land). No bands are detected in MDBK cell extracts blotted
with the anti-calretinin antibody (data not shown).







correlates with the level of the VDR, the relative level of VDR
expression in the four renal cell lines was assessed by specific
binding of 3H-1 ,25(OH)2D3. As indicated in Figure 2, the Nmax
of l,25(OH)2D3 is significantly higher in MDBK cells (260
fmol/mg protein) than in either MDCK (13 fmol/mg protein),
LLC-PK1 (47 fmol/mg protein) or OK (43 fmollmg protein)
cells. Previous work in our lab [10] has verified that the
approximate molecular weight and Kd of the 1 ,25(OH)2D3
binding component in MDBK cells are comparable to that of the
mammalian VDR assessed in tissue samples and/or cell lines
[14, 15].
Since calbindin D-28K is exclusively localized to the distal
nephron in vivo, MAB 474, a commercially available monoclo-
nal antibody raised against a marker protein for human distal
tubules, was used to further establish the origin of the four cell
lines. The majority of MDBK cells (Fig. 3a) exhibit homoge-
neous immunoreactivity, clearly indicating that these cells
retain this distal tubule characteristic in vitro. The expression of
the distal tubule marker protein is present, but faint, in MDCK
cells (Fig. 3b), and is absent in LLC-PK1 and OK cells (Fig. 3c,
d).
Effect of serum on MDBK cell proliferation, VDR and
calbindin D-28K
Since only MDBK cells expressed both the VDR and calbin-
din D-28K, the regulation of calbindin D-28K was further
studied in this cell line. Previous reports have suggested that
expression of both the VDR and calbindin D-28K is highest in
rapidly proliferating cells [8, 161. We therefore compared 3H-
1 ,25(OH)2D3 binding, calbindin D-28K expression and 3H-
thymidine incorporation in MDBK cells grown in 10% serum to
cells grown under serum free conditions. As shown in Figure
4A, MDBK cells grown in serum exhibit significantly higher
28 kD —0'
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Fig. 2. Specific binding of 3H-1,25(OH)2D3 in MDBK, MDCK, LLC-
PI(, and OK cells. Cells were grown in serum containing media,
harvested by scraping, and high salt extracts were incubated with 0.5
nM 3H-l,25(OH)2D3 overnight at 4°C as described in text. Data are
expressed as mean SEM (N = 4 to 8) of specific 3H-l,25(OH)2D3
binding, obtained by subtraction of nonspecific binding from total
binding. Statistical differences between groups were assessed by
ANOVA.
MDBK MDCK LLC-PK1 OK
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Fig. 3. Immunofluorescence of distal tubule marker protein in MDBK,
MDCK, LLC-PK1 and OK cells. Cells were grown on coverslips in
media containing 10% serum, washed and fixed in cold ethanol and
incubated with MAB 474 antibody directed against the distal tubule
marker protein, followed by FITC-labeled secondary antibody as
described in the Methods. Cells were mounted and viewed under phase
contrast (left panels) and fluorescence (right panels). A. MDBK cells; B.
MDCK cells; C. LLC-PK1 cells; D. OK cells. Magnification 200x.
3H- 1 ,25(OH)2D3 binding than cells in serum free media. Cells
grown in serum also exhibit more intense immunoreactive
calbindin D-28K than cells grown in the absence of serum (Fig.
4B). The amount of calbindin D-28K in MDBK cells grown in
serum, quantitated by ELISA, is 70.4 6.3 g/l00 mg protein
compared to 28.8 0.7 g/l0O mg protein for cells grown in
serum free media for 24 hours (mean SEM;N = 5). MDBK
cells grown in serum exhibited threefold higher rates of 3H-
thymidine incorporation than cells grown in serum free medium
for 24 hours (Fig. 4C).
Induction of calbindin D-28K by 1,25(OH)2D3 in MDBK cells
To study the effect of 1,25(OH)2D3 on calbindin D-28K
expression, MDBK cells were grown in serum free media for 24
hours prior to treatment with 1,25(OH)2D3 or vehicle. En-
hanced expression of calbindin D-28K in 1 ,25(OH)2D3 treated
cells was readily detectable by both immunoblotting and immu-
nofluorescence (Fig. 5). On Western blots (Fig. 5a), the total
amount of immunoreactive calbindin D-28K was substantially
elevated in MDBK cells incubated in the presence of tO M
1 ,25(OH)2D3 for 24 hours compared to vehicle treated cells.
Calbindin D-28K was detectable by immunofluoresence in
virtually every MDBK cell in the culture, regardless of whether
the cells were grown in the presence or absence of 1 ,25(OH)2D3









Fig. 4. Effect of serum on specific 'H-1,25(OH)2D3 binding, calbindin
D-28K and 3H-thymidine incorporation in MDBK cells. MDBK cells
were grown to confluence as described in the Methods, at which time
media was replaced with fresh media containing 10% serum (white bars)
or no serum (black bars). Cells were harvested 24 hours later and
analyzed for (A) specific H-l,25(OH)2D3 binding, (B) calbindin D-28K
and (C) thymidine incorporation as described in the Methods. For A and
C the statistical differences between growing and quiescent cells was
assessed by Student's t-test and considered significant (P < 0.05).
cells grown in the presence of 1,25(OH)2D3 (10—v M, 24 hr; Fig.
Sc) compared to untreated cells (Fig. 5b). In both control and
1 ,25(OH)2D3 treated cells, the majority of immunoreactive
calbindin D-28K was detected in the cytosol, but was distinctly
concentrated in the perinuclear region. In 1 ,25(OH)2D3 treated
cells, calbindin D-28K was also consistently detected within the
nucleus.
The time course of calbindin D-28K induction by
1,25(OH)2D3, measured by ELISA, is shown in Figure 6.
Calbindin D-28K expression increases within two hours after
addition of iO M l,25(OH)2D3, with a significant increase
detected by four hours. At 8 and 24 hours, the increase in
calbindin D-28K in cells treated with 1 ,25(OH)2D3 was 1.6- and
1.4-fold, respectively, compared to vehicle controls. The level
of calbindin D-28K in vehicle treated control cells was not
altered over the 24-hour time course experiment. Dose re-
sponse studies indicated that doses as low as i0 M increase
calbindin D-28K expression, and that maximal induction was
achieved with i0 M 1,25(OH)2D3 (Fig. 7).
The role of new protein synthesis in calbindin D-28K induc-
tion by 1 ,25(OH)2D3 was studied by pretreatment of MDBK























Gagnon et al: calbindin D-28K and vitamin D 99
A
28 kD —
Fig. 5. Effect of 1,25(OH)2D3 on calbindin D-28K in MDBK cells. Serum-free MDBK cells were treated with iO- M 1,25(OH)2D3 in ethanol or
vehicle for 24 hours. (A) Total cell homogenate proteins (100 gIlane) were electrophoresed on 15% SDS-polyacrylamide gels, transferred to
nitrocellulose and blotted with monoclonal anti-calbindin D-28K as described in text. Lane I: vehicle treated; lane 2: 1,25(OH)2D3 treated. (B, C)
Cells were grown on coverslips, fixed in cold ethanol and incubated with anti-calbindin D-28K monoclonal antibody, followed by FITC-labeled
secondary antibody as described in Methods. Cells were then mounted and viewed with a Zeiss fluorescence microscope. B, vehicle treated; C,
1 ,25(OH)2D3 treated. Magnification 250x.
cells, cycloheximide treatment slightly reduced calbindin
D-28K (Fig. 8). In 1 ,25(OH)2D3 treated cells, cycloheximide
treatment reduced calbindin D-28K expression below that of
ethanol treated cells exposed to cycloheximide, thereby abol-
ishing the induction of calbindin D-28K by 1 ,25(OH)2D3.
Since we observed an association between cell proliferation
and expression of the VDR and calbindin D-28K in MDBK
cells, the effect of 1 ,25(OH)2D3 on MDBK cell proliferation was
assessed in parallel studies. The data indicated that, under
serum free conditions where MDBK cells were essentially
quiescent, 24 hour exposure to iO M 1 ,25(OH)2D3 had no
effect on 3H-thymidine incorporation (ethanol control: 13,000
944; 1 ,25(OH)2D3 treated: 13,000 942, cpm 3H-incorporated/
dish; N = 6).
Discussion
Investigation into the molecular regulation of renal calbindin
D-28K expression has been extremely limited due to the lack of
an established cell line which expresses calbindin D-28K in a
vitamin D responsive manner. The primary culture systems in
which calbindin D-28K induction by 1,25(OH)2D3 have been
characterized are derived from collagenase digestion of fresh
kidney [7, 8]. The avian system has been shown to exhibit
25(OH)D3 la-hydroxylase activity, which in vivo is confined to
proximal tubules [17]. In the rat system, the observation of Na-
dependent phosphate transport likewise indicates the presence
of proximal tubular cells [18]. Thus, the previously described
primary cultures are heterogeneous mixtures of proximal and








Fig. 6. Time course of 1,25(OH)2D3 induction of calbindin D-28K
immunoreaceivity in MDBK cells. Serum-free MDBK cells were treated
with l0 M 1 ,25(OH)2D3 in ethanol or vehicle for up to 24 hours.
Cytosolic levels of calbindin D-28K were measured by ELISA as
described in the Methods. Calbindin D-28K was significantly (P < 0.05)
higher in 1 ,25(OH)2D3 treated cells compared to vehicle treated cells
after 8 and 24 hours, as determined by Student's t-test for unpaired data
at each time point.
cells with 2 ILM cycloheximide followed by exposure to
1,25(OH)2D3 or vehicle for 24 hours. This dose of cyclohexi-
nude inhibited protein synthesis by 75%, as measured by
3H-leucine incorporation (data not shown). In vehicle treated
1 2
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Fig. 7. Dose-response of 1,25(OH)2D3 induction of calbindin D-28K
immunoreactivity in MDBK cells. Serum-free MDBK cells were treated
with various concentrations of 1 ,25(OH)2D3 in ethanol or vehicle for 24
hours. Cytosolic proteins (100 sg/lane) were electrophoresed on 15%
SDS-polyacrylamide gels, transferred to nitrocellulose and blotted with
monoclonal anti-calbindin D-28K as described in text. Lane 1: vehicle-
treated; lanes 2 to 5: treated with iO— 64, 10—8 M, l0— M and 10—6 M
1 ,25(OH)2D3, respectively.
distal tubular cells, complicating the study of the regulation of
calbindin D-28K, which is not expressed in the proximal tubule
of either rat or chick [1, 19—211. In the studies described here,
we have examined calbindin D-28K expression in four renal cell
lines [OK (opposum kidney), LLC-PK1 (pig kidney), MDCK
(Madin-Darby canine kidney) and MDBK (Madin-Darby bovine
kidney)] to identify a cell line that expresses calbindin D-28K in
a vitamin D3 dependent manner. Since calbindin D-28K is
expressed exclusively in the distal nephron in vivo [1, 19—21],
we have established whether the four renal cell lines express the
distal tubular marker protein recognized by the commercially
available monoclonal antibody MAB 474. We have further
analyzed each cell line to determine whether they express
calbindin D-28K and the VDR, and, if so, whether calbindin
D-28K expression could be up-regulated by 1 ,25(OH)2D3.
Both OK cells and LLC-PK1 cells represent renal epithelial
cell lines which display Na-dependent transport of glucose,
phosphate and amino acids, characteristics of the proximal
nephron in vivo. Neither of these cell lines expressed the distal
tubular marker protein or calbindin D-28K (Figs. 1, 3). Al-
though lack of immunoreactivity for calbindin D-28K could
reflect species differences in recognition by the monoclonal
antibody, the known homology between calbindin D-28K pro-
teins from divergent species [22] argues against this intepreta-
tion. Moreover, negative results were also obtained for OK and
LLC-PK1 cells with a distinct polyclonal antibody directed
against rat renal calbindin D-28K (Fig. 1). Both OK and
LLC-PK1 cell lines exhibit H-l ,25(OH)2D binding, although
the level of the VDR is substantially lower than that observed in
MDBK cells, suggesting that these cell lines represent proximal
tubular-like renal cell lines which do not express calbindin
D-28K despite the presence of the VDR. These results are
2 3 4
Fig. 8. Effects of cycloheximide on 1,25(OH)2D3 induction of calbindin
D-28K in MDBK cells. Serum-free MDBK cells were pretreated for 1
hour with 2 /LM cycloheximide in PBS or vehicle alone. Cells were then
treated with l0- as 1 ,25(OH)2D in ethanol or vehicle for 24 hours.
Cytosolic proteins (100 gflane) were electrophoresed on 15% SDS-
polyacrylamide gels, transferred to nitrocellulose and blotted with
monoclonal anti-calbindin D-28K as described in text. Lane I: vehicle;
lane 2: cycloheximide; lane 3: l,25(OH)2D3 and cycloheximide; lane 4:
1 ,25(OH)2D3.
consistent with the literature documenting the presence of the
VDR in both proximal nephron [231 and LLC-PK1 cells [14],
and the absence of calbindin D-28K in proximal tubules [1, 19—
21].
The MDCK and MDBK cell lines were originally established
from normal canine and bovine kidney, respectively [24, 25].
Although the biochemical characteristics of the MDBK cell line
have not been extensively studied, MDCK cells are known to
retain enzyme markers, morphological features and antigenic
determinants of distal tubule cells [26—28]. Thus, MDCK cells
are considered to be well-differentiated distal tubular-like cells,
although some studies have suggested heterogeneity within and
between MDCK cell cultures and several distinct sub-clones
have been generated from the original MDCK line [27, 29, 30].
Comparison of the MDCK and MDBK cell lines obtained from
ATCC demonstrated that both of these cell lines exhibit immu-
noreactivity towards the distal tubular marker protein, although
the relative intensity is considerably greater in MDBK cells. In
parallel with expression of the distal tubular marker, calbindin
D-28K is expressed in MDBK cells and undetectable in MDCK
cells. Further, the relative expression of the VDR (high in
MDBK cells and low in MDCK cells) correlates to the relative
expression of both calbindin D-28K and the distal tubule marker
protein. These findings are consistent with earlier work by
Colston and Feldman [14], who reported that MDCK cells lack
specific binding sites for 1 ,25(OH)2D3. Thus, although MDCK
cells retain certain characteristics of distal tubule cells, they
apparently lack the vitamin D dependent pathway leading to
calbindin D-28K expression which is known to be present in the
distal nephron in vivo. In contrast, MDBK cells express both
VDRs and calbindin D-28K, and thus represent the best candi-
date cell line for studying the regulation of renal calbindin
D-28K expression.
The basal expression of calbindin D-28K in MDBK cells (28.0
2.4 sgJ100 mg protein) is comparable to that of primary renal
7
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cultures from chick (5 to 24 jsg/100 mg protein) or rat (37 to 85
jg/100 mg protein) [7, 8]. In contrast to the avian primary
culture system, where only a minority of cells within the
cultures expressed calbindin D-28K, even in the presence of
1,25(OH)2D3 [7], virtually every MDBK cell in culture ex-
presses calbindin D-28K. Exposure of MDBK cells for 24 hours
to a single dose of 1 ,25(OH)2D3 increases calbindin D-28K at
concentrations as low as i0 M, with the peak effect observed
at a concentration of i0 M 1 ,25(OH)2D3. This dose response
is similar to that reported for avian primary cultures [7]. The
magnitude (1.6-fold) of induction by i0 M 1 ,25(OH)2D3 in
MDBK cells is similar to that seen in primary renal cultures, in
which io— M 1 ,25(OH)2D3 elicited a 1.3- to 2.0-fold increase in
calbindin D-28K in rat and chick preparations [7, 8]. In vivo, the
difference in renal calbindin D-28K level between vitamin D
replete and vitamin D deficient rats is less than threefold [31].
Cycloheximide treatment abolished the effect of 1 ,25(OH)2D3
on calbindin D-28K in MDBK cells, as has been reported in
avian primary cultures [7]. These data, documenting the induc-
tion of calbindin D-28K by 1 ,25(OH)2D3 in a time and dose
dependent manner which is sensitive to cycloheximide, suggest
that MDBK cells mimic the expression of renal calbindin D-28K
in vivo. Preliminary data from our laboratory indicate that, like
mammalian kidney [22], MDBK cells also express the smaller
vitamin D-dependent calcium-binding protein, calbindin D-9K.
Further studies will be needed to determine whether
1 ,25(OH)2D3 also regulates calbindin D-9K expression in these
cells.
Although calbindin D-28K is described as a cytosolic calcium
binding protein, the absence of a cell culture system which
expresses calbindin D-28K in a vitamin D responsive manner
has precluded a detailed examination of calbindin D-28K sub-
cellular distribution. In MDBK cells, the vast majority of
calbindin D-28K is localized to the cytosol, yet a definite
pen-nuclear localization is evident. Some immunoreactivity is
observed in the nucleus itself, particularly in 1,25(OH)2D3
treated cells. These data are consistent with reports indicating
localization of calbindin D-28K in both cytosol and nucleus of
chick and rat renal sections [20, 21]. In contrast, calbindin
D-28K immunoreactivity is low or absent in nuclei of avian
primary cultures [7]; the reason for this discrepancy is unclear
at present. In view of our observation that calbindin D-28K is
up-regulated during the proliferative growth phase in MDBK
cells, more detailed studies on subcellular distribution of cal-
bindin D-28K during the cell cycle are warranted.
Our data indicate that both calbindin D-28K and VDR ex-
pression are up-regulated in MDBK cells grown in 10% serum
compared to cells grown for 24 hours in the absence of serum.
Although stimulation of 1 ,25(OH)2D3 binding in response to
serum and growth factors has been reported in fibroblasts and
MCF-7 cells [32], our data are the first to demonstrate that
serum stimulation is associated with up-regulation of renal
calbindin D-28K. Since serum stimulation of calbindin D-28K
expression in MDBK cells is associated with up-regulation of
the VDR, the effect of serum may involve increased sensitivity
of the cells to 1 ,25(OH)2D3. Preliminary studies in our lab
indicate that growth factors such as epidermal growth factor
and insulin can modulate calbindin D-28K expression in MDBK
cells cultured in the absence of 1 ,25(OH)2D3 (unpublished
observations). We have also shown that the phorbol ester TPA
down-regulates calbindin D-28K expression in MDBK cells [9],
suggesting an involvement of the protein kinase C signaling
pathway in calbindin D-28K regulation. Taken collectively,
these data emphasize the complexity of renal calbindin D-28K
expression and indicate the importance of factors in addition to
1 ,25(OH)2D3 in modulation of calbindin D-28K expression. In
this regard, the MDBK cell system represents a unique and
valuable tool to probe the interactions between 1 ,25(OH)2D3
and other signal transduction pathways in the coordinate regu-
lation of renal calbindin D-28K.
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